 |
Pfizer appoints Elif Aral as Regional PresidentPfizer has announced the appointment of Elif Aral as Regional President for Middle East, Russia, and Africa (MERA) effective September 2024. She will spearhead operations in the region and bring scientific breakthroughs in vaccines, oncology, More… |
 |
Pfizer reflects on 175-year global legacy, breakthroughsPfizer has commemorated its 175-year anniversary in Dubai on June 11, by reflecting on the significant contributions made in the global and regional medical landscape while looking ahead at what is yet to come. More… |
 |
Lorlatinib helps lung cancer patients live longer: PfizerPfizer’s Phase 3 CROWN trial evaluating Lorlatinib for the treatment of lung cancer has found that the majority of patients are living beyond five years without disease progression. After five years of me More… |
 |
Pfizer reveals key findings of Sickle Cell Disease surveyPfizer, a leading multinational pharmaceutical and biotechnology company, has revealed key findings from a survey conducted in several countries, including the GCC, on sickle cell disease (SCD). Results o More… |
 |
Pfizer launches ‘Know. Plan. Go.’ campaign in the Gulf regionPfizer has rolled out ‘Know. Plan. Go.’ campaign in countries across the Gulf region to raise awareness on viral respiratory diseases and the steps people can take to help prevent severe illness. More… |
 |
Pfizer expands ‘Accord’ to benefit 1.2bn people in 45 countriesPfizer has significantly expanded its commitment to An Accord for a Healthier World to offer the full portfolio of medicines and vaccines to enable greater health for 1.2 billion people living in 45 lower-income countries. & More… |
 |
Pfizer appoints Bains as Gulf Cluster Country ManagerPfizer has announced the appointment of Dr Parmjot Bains as Gulf Cluster Country Manager within its Emerging Markets business unit. Dr Bains’ experience spans more than 18 years in various fields wi More… |
 |
Pfizer offers medicines on not-for-profit basis to 45 nationsPfizer, one of the world's premier biopharmaceutical firms, has launched a groundbreaking initiative to supply medicines and vaccines on a not-for-profit basis to 1.2 billion people in 45 lower-income countries. More… |
|
Pfizer offers medicines on not-for-profit basis to 45 nationsPfizer, one of the world's premier biopharmaceutical firms, has launched a groundbreaking initiative to supply medicines and vaccines on a not-for-profit basis to 1.2 billion people in 45 lower-income countries. More… |
 |
Pfizer aims to deliver breakthroughs to more patientsRegional leaders from Pfizer in Africa and the Middle East region (AfME) announced their plans for delivering breakthroughs to more patients across the region, aiming to impact more than 45 percent more people in 2022 versus 2021. More… |
